Within Chapter 30 – Pharmaceutical Products, HSN Code 30036000 serves as the official classification for Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter. This code determines tax rates and compliance obligations for all entities trading in Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter. CGST applies at 0.06, SGST/UTGST at 0.06 for local transactions, and IGST at 0.12 for interstate supplies. Measurement is standardized in kg..

Below are related HSN codes from Chapter 30 – Pharmaceutical Products for your reference:

The tax structure for Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter under HSN Code 30036000 follows a dual taxation model. CGST is levied at 0.06 and SGST/UTGST at 0.06 for intrastate sales. Interstate transactions attract IGST at 0.12. All invoices must record quantities in kg. as the standard measurement for goods under Chapter 30 – Pharmaceutical Products.

Traders, manufacturers, and importers of Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter are required to mention HSN Code 30036000 on all GST documents. This Pharmaceutical Products classification under Chapter 30 is mandatory for compliance across all business formats including online sellers.

Commencing trade in Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter? Secure GST registration to handle taxes on HSN 30036000 classified goods. Businesses with international operations in Pharmaceutical Products need an Import Export Code. Exporters require AD Code registration for foreign currency receipts. Start with company registration to formalize your business structure.

Accurate application of HSN Code 30036000 for Other, Containing Antimalarial Active Principles Described In Sub-Heading Note 2 To This Chapter enables legitimate input tax credit claims and prevents assessment disputes. Businesses under Chapter 30 – Pharmaceutical Products should monitor rate updates (0.06, 0.06, 0.12) through official notifications to maintain seamless compliance.